SCHEMBL4904076

SCHEMBL4904076

CCc1ccc(S(=O)(=O)NCCSc2ncccc2C(F)(F)F)cc1C(=O)OC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.39
TSHR P16473 3/20 0.39
HTT P42858 3/20 0.39
USP2 O75604 2/20 0.39
HSD17B10 Q99714 2/20 0.38
L3MBTL1 Q9Y468 3/20 0.37
PKM P14618 2/20 0.37
KMT2A Q03164 3/20 0.37
MAPT P10636 2/20 0.37
POLB P06746 1/20 0.37
IDH2 P48735 1/20 0.37
MEN1 O00255 2/20 0.36
LMNA P02545 4/20 0.36
PTGDR2 Q9Y5Y4 1/20 0.35
HSD11B1 P28845 1/20 0.35
HPGD P15428 1/20 0.34
MAPK1 P28482 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
CFTR P13569 1/20 0.34
CYP1A2 P05177 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4903694 0.91 ALDH1A1 (0.40) ALDH1A1TSHRHTTUSP2HSD17B10
SCHEMBL4899948 0.91 LMNA (0.40) ALDH1A1TSHRHTTUSP2HSD17B10
SCHEMBL4907291 0.83 LMNA (0.50) ALDH1A1TSHRHTTUSP2HSD17B10
SCHEMBL4895719 0.81 ALDH1A1 (0.48) ALDH1A1HTTUSP2L3MBTL1PKM
SCHEMBL4906080 0.79 ALDH1A1 (0.47) ALDH1A1TSHRHTTHSD17B10L3MBTL1
SCHEMBL4904091 0.79 ALDH1A1 (0.40) ALDH1A1TSHRHTTL3MBTL1PKM
SCHEMBL4898221 0.79 ALDH1A1 (0.46) ALDH1A1TSHRHTTUSP2HSD17B10
SCHEMBL4903898 0.78 ALDH1A1 (0.47) ALDH1A1TSHRHTTHSD17B10L3MBTL1
SCHEMBL4900064 0.76 ALDH1A1 (0.52) ALDH1A1TSHRHTTHSD17B10KMT2A
SCHEMBL4895942 0.75 ALDH1A1 (0.50) ALDH1A1TSHRHTTPKMKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD ALDH1A1 2664/4885TSHR 412/4885HTT 711/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD ALDH1A1 2956/4885TSHR 400/4885HTT 696/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.